NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Novo Nordisk A/S (CO: NOVO-B)

 
NOVO-B Technical Analysis
5
As on 30th Jun 2025 NOVO-B STOCK Price closed @ 439.60 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 859.97 & Strong Sell for SHORT-TERM with Stoploss of 816.66 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NOVO-BSTOCK Price

Open 441.05 Change Price %
High 446.35 1 Day 2.10 0.48
Low 438.00 1 Week -48.80 -9.99
Close 439.60 1 Month 1.00 0.23
Volume 4362903 1 Year -283.50 -39.21
52 Week High 1028.00 | 52 Week Low 390.00
 
CO Denmark Most Active Stocks
SAS 0.01 0.00%
VWS 95.02 -7.97%
NOVO-B 439.60 0.48%
CONFRZ 0.02 0.00%
GREENH 0.41 -6.82%
DANSKE 258.30 -0.46%
ASTRLS 1.15 8.49%
ALMB 16.92 0.53%
VJBA 4.72 -1.26%
BLVIS-A 0.40 -18.37%
 
CO Denmark Top Gainers Stocks
FOM 10.25 62.70%
FOM 10.25 62.70%
HYDRCT 0.60 46.34%
HYPE 3.66 22.00%
DKIEEU 249.00 15.81%
KLEE-B 3980.00 11.80%
GREENM 39.70 10.89%
SAME 1.45 10.69%
SAME 1.45 10.69%
ALEFRM 1.66 9.21%
 
CO Denmark Top Losers Stocks
VALUER 0.25 -21.88%
BLVIS-A 0.40 -18.37%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
ACT 0.72 -12.20%
 
 
NOVO-B
Daily Charts
NOVO-B
Intraday Charts
Whats New @
Bazaartrend
NOVO-B
Free Analysis
 
NOVO-B Important Levels Intraday
RESISTANCE455.69
RESISTANCE450.53
RESISTANCE447.34
RESISTANCE444.15
SUPPORT435.05
SUPPORT431.86
SUPPORT428.67
SUPPORT423.51
 
NOVO-B Forecast July 2025
4th UP Forecast725.95
3rd UP Forecast634.12
2nd UP Forecast577.35
1st UP Forecast520.59
1st DOWN Forecast358.61
2nd DOWN Forecast301.85
3rd DOWN Forecast245.08
4th DOWN Forecast153.25
 
NOVO-B Weekly Forecast
4th UP Forecast478.91
3rd UP Forecast466.30
2nd UP Forecast458.51
1st UP Forecast450.72
1st DOWN Forecast428.48
2nd DOWN Forecast420.69
3rd DOWN Forecast412.90
4th DOWN Forecast400.29
 
NOVO-B Forecast2025
4th UP Forecast1698.32
3rd UP Forecast1294.64
2nd UP Forecast1045.12
1st UP Forecast795.59
1st DOWN Forecast83.61
2nd DOWN Forecast-165.92
3rd DOWN Forecast-415.44
4th DOWN Forecast-819.12
 
 
NOVO-B Other Details
Segment EQ
Market Capital 1565371138048.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NOVO-B Address
NOVO-B
 
NOVO-B Latest News
 
Your Comments and Response on Novo Nordisk A/S
 
NOVO-B Business Profile
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark. Address: Novo Allé 1, Bagsvaerd, Denmark, 2880
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service